Your Tasks
- Design and conduct radioligand therapy studies in vitro and in cancer mouse models to preclinically develop safe and efficacious innovative cancer treatments.
- Investigate tumor biology and tumor-microenvironment interactions, including target expression, tumor heterogeneity, treatment response, and resistance mechanisms, to support rational therapy development and optimization.
- Work in an interdisciplinary environment, collaborating closely with research partners and supporting the team with data and scientific expertise.
- Analyze and report experimental results through scientific presentations and publications with a focus on clinical translation.
Your Profile
- PhD degree in radioligand therapy, cancer therapeutics, tumor biology, or a related field.
- Experience in cancer mouse models; prostate cancer model experience is an advantage.
- Willingness to work with radionuclides and mouse models is essential.
- Knowledge of drug screens and omics technologies (e.g., Proteomics) is a plus.
- Strong motivation, excellent communication, and presentation skills in English.
We Offer
Our institution is based on interdisciplinary, innovative, and dynamic collaboration. You will benefit from systematic on-the-job training, along with personal development opportunities and a strong vocational training culture. We support a balanced work-life integration with modern employment conditions and onsite infrastructure.
Your employment contract is limited to 2 years.
For further information, please contact Dr. Michal Grzmil via email at michal.grzmil@psi.ch.
Apply online using the form below. Only applications matching the job profile will be considered.
Paul Scherrer Institute, Human Resources Management, Pascale Bärtschi, 5232 Villigen PSI, Switzerland.